- Home
- CRDF vs AVD Comparison
CRDF vs AVD Comparison
Compare CRDF & AVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRDF | AVD |
|---|---|---|
| Founded | 1999 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 142.1M | 144.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CRDF | AVD |
|---|---|---|
| Price | $2.93 | $3.88 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $10.63 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 914.5K | 203.9K |
| Earning Date | 11-06-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $501,000.00 | ★ $530,073,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.54 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.90 | $3.28 |
| 52 Week High | $5.00 | $6.33 |
Technical Indicators
Market Signals| Indicator | CRDF | AVD |
|---|---|---|
| Relative Strength Index (RSI) | 76.82 | 32.69 |
| Support Level | $2.32 | $3.84 |
| Resistance Level | $2.59 | $4.02 |
| Average True Range (ATR) | 0.15 | 0.19 |
| MACD | 0.05 | -0.03 |
| Stochastic Oscillator | 99.34 | 5.03 |
Price Performance
Historical ComparisonAbout CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About AVD American Vanguard Corporation ($0.10 Par Value)
American Vanguard Corp is a United States-based diversified specialty and agricultural products company. It manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.